首页> 外国专利> CRYSTALLINE SOLVATES AND COMPLEXES OF (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL)METHYL)PHENYL)-D-GLUCITOL DERIVATIVES HAVING AMINO ACIDS AS SGLT2 INHIBITORS FOR TREATING DIABETES

CRYSTALLINE SOLVATES AND COMPLEXES OF (1S)-1,5-ANHYDRO-1-C-(3-((PHENYL)METHYL)PHENYL)-D-GLUCITOL DERIVATIVES HAVING AMINO ACIDS AS SGLT2 INHIBITORS FOR TREATING DIABETES

机译:结晶溶剂和(1S)-1,5-脱水-1-C-(3-(((苯基)甲基)苯基)-D-葡糖醇衍生物的氨基乙酸作为SGLT2抑制剂治疗糖尿病。

摘要

To provide novel free acid polymorphic crystals of SGLT2 inhibitors, production methods of the crystals, and pharmaceutical compositions containing the crystals, which possess an effect of inhibiting the sodium dependent glucose transporters (SGLT2) in the intestine and kidney of mammals and are useful in treatment of diabetes, diabetic complications, and the like.SOLUTION: The invention provides a crystal of a compound I represented by the formula in the figure, which is selected from the group consisting of ethylene glycol (EG) crystal (form SB-1), ethylene glycol (EG) crystal (form SB-2), 1:2 L-proline crystal (form 3), 1:1 L-proline crystal (form 6), and 1:1 L-proline hemihydrate crystal (form H.5-2).SELECTED DRAWING: None
机译:为了提供新的SGLT2抑制剂的游离酸多晶型晶体,该晶体的生产方法以及包含该晶体的药物组合物,其具有抑制哺乳动物的肠和肾中钠依赖性葡萄糖转运蛋白(SGLT2)的作用并且可用于治疗解决方案:本发明提供了由图中的化学式表示的化合物I的晶体,该晶体选自乙二醇(EG)晶体(SB-1形式),乙二醇(EG)晶体(SB-2形式),1:2 L-脯氨酸晶体(形式3),1:1 L-脯氨酸晶体(形式6)和1:1 L-脯氨酸半水合物晶体(形式H. 5-2)。选定的图纸:无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号